Synta Pharmaceuticals, Inc. (SNTA) Reports Q3 Loss of $0.30
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Financial Fact:
General and administrative: 6.29M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
General and administrative: 6.29M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q3 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.71 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Nomad Foods Limited (NOMD) Tops Q2 EPS by 6c; offers guidance
- Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
